• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Semler Scientific Inc.

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SMLR alert in real time by email
    SC 13G 1 tm2429550d1_sc13g.htm SC 13G

     

    CUSIP No: 81684M104

     

     

     

      SECURITIES AND EXCHANGE COMMISSION  
      Washington, D.C. 20549  

     

     

     

    SCHEDULE 13G

     

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2.

     

    (Amendment No.  )*

     

    Semler Scientific, Inc.

    (Name of Issuer)

     

    Common Stock, $0.001 par value per share

     (Title of Class of Securities)

     

    81684M104

    (CUSIP Number)

     

    November 20, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)
       
    x Rule 13d-1(c)
       
    ¨ Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No: 81684M104

     

    (1) Names of Reporting Persons
    Capital Ventures International
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)  
      (a) ¨
      (b) ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Cayman Islands
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    550,072 (1)(2)
     
    (6) Shared Voting Power
    557,952 (1)
     
    (7) Sole Dispositive Power
    550,072 (1)(2)
     
    (8) Shared Dispositive Power
    557,952 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    557,952 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    7.7%
     
    (12) Type of Reporting Person (See Instructions)
    CO
               

     

    (1) G1 Execution Services, LLC and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

    (2) Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.

     

     

     

     

    CUSIP No: 81684M104

     

    (1) Names of Reporting Persons
    Susquehanna Advisors Group, Inc.
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)  
      (a) ¨
      (b) ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Pennsylvania
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    0 (1)(2)
     
    (6) Shared Voting Power
    557,952 (1)
     
    (7) Sole Dispositive Power
    0 (1)(2)
     
    (8) Shared Dispositive Power
    557,952 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    557,952 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    7.7%
     
    (12) Type of Reporting Person (See Instructions)
    CO
               

     

    (1) G1 Execution Services, LLC and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

    (2) Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.

     

     

     

     

    CUSIP No: 81684M104

     

    (1) Names of Reporting Persons
    G1 Execution Services, LLC
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)  
      (a) ¨
      (b) ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Illinois
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    5,422 (1)
     
    (6) Shared Voting Power
    557,952 (1)
     
    (7) Sole Dispositive Power
    5,422 (1)
     
    (8) Shared Dispositive Power
    557,952 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    557,952 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    7.7%
     
    (12) Type of Reporting Person (See Instructions)
    BD, OO
               

     

    (1) G1 Execution Services, LLC and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 81684M104

     

    (1) Names of Reporting Persons
    Susquehanna Securities, LLC
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)  
      (a) ¨
      (b) ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Delaware
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    2,458 (1)
     
    (6) Shared Voting Power
    557,952 (1)
     
    (7) Sole Dispositive Power
    2,458 (1)
     
    (8) Shared Dispositive Power
    557,952 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    557,952 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    7.7%
     
    (12) Type of Reporting Person (See Instructions)
    BD, OO
               

     

    (1) G1 Execution Services, LLC and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 81684M104

     

    Item 1.
      (a)

    Name of Issuer

     

    Semler Scientific, Inc. (the “Company”)

      (b)

    Address of Issuer’s Principal Executive Offices

    2340-2348 Walsh Avenue, Suite 2344
    Santa Clara, CA 95051

     
    Item 2(a).  

    Name of Person Filing

     

    This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons” with respect to the shares of Common Stock, $0.001 par value per share, of the Company (the “Shares”).

     

    (i)         Capital Ventures International

    (ii)        Susquehanna Advisors Group, Inc.

    (iii)       G1 Execution Services, LLC

    (iv)       Susquehanna Securities, LLC

     

    Item 2(b).  

    Address of Principal Business Office or, if none, Residence

     

    The address of the principal business office of Capital Ventures International is:

     

    P.O. Box 897

    Windward 1, Regatta Office Park

    West Bay Road

    Grand Cayman, KY1-1103

    Cayman Islands

     

    The address of the principal business office of G1 Execution Services, LLC is:

     

    175 W. Jackson Blvd.

    Suite 1700

    Chicago, IL 60604

     

    The address of the principal business office of each of Susquehanna Advisors Group, Inc., and Susquehanna Securities, LLC is:

     

    401 E. City Avenue

    Suite 220

    Bala Cynwyd, PA 19004

     

    Item 2(c).   Citizenship
    Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
    Item 2(d).   Title of Class of Securities
    Common Stock, $0.001 par value per share
    Item 2(e)  

    CUSIP Number

    81684M104

     

     

     

     

    CUSIP No: 81684M104

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨ A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with rule 13d–1(b)(1)(ii)(K).
          If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:                                                        
           

    Item 4. Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    The Company’s Quarterly Report on Form 10-Q, filed on November 5, 2024, indicates that there were 7,266,242 Shares outstanding as of October 31, 2024.

      

    Item 5. Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:   ¨

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person
       

    Not applicable.

     

     

     

     

    CUSIP No: 81684M104

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
       
    Not applicable.
     
    Item 8. Identification and Classification of Members of the Group
       
    Not applicable.
     
    Item 9. Notice of Dissolution of Group
       
    Not applicable.

     

    Item 10. Certification
       
    By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No: 81684M104

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

     

    Dated: November 26, 2024

     

    CAPITAL VENTURES INTERNATIONAL   SUSQUEHANNA ADVISORS GROUP, INC.
       
    By: Susquehanna Advisors Group, Inc. pursuant to a Limited Power of Attorney, a copy of which is attached as Exhibit I hereto  
         
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name: Brian Sopinsky
    Title: Assistant Secretary   Title: Assistant Secretary
           
    G1 EXECUTION SERVICES, LLC   SUSQUEHANNA SECURITIES, LLC
       
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name: Brian Sopinsky
    Title: Secretary   Title: Secretary

     

     

     

     

    CUSIP No: 81684M104

     

    EXHIBIT INDEX

      

    EXHIBIT   DESCRIPTION
         
    I   Limited Power of Attorney executed by Capital Ventures International in favor of Susquehanna Advisors Group, Inc., dated as of December 4, 2012
         
    II   Joint Filing Agreement 

     

     

     

    Get the next $SMLR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SMLR

    DatePrice TargetRatingAnalyst
    11/2/2022$60.00 → $45.00Buy → Neutral
    B. Riley Securities
    3/7/2022$145.00 → $70.00Buy
    B. Riley Securities
    11/2/2021$175.00 → $145.00Buy
    B. Riley Securities
    10/26/2021$151.00 → $175.00Buy
    B. Riley Securities
    More analyst ratings

    $SMLR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Semler Scientific® Appoints Natalie Brunell to its Board of Directors

      CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci

      5/19/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC

      CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a

      5/13/25 4:01:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 2025 Financial Results

      SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe

      4/30/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Leadership Updates

    Live Leadership Updates

    See more
    • Semler Scientific® Appoints Natalie Brunell to its Board of Directors

      CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci

      5/19/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining

      SANTA CLARA, Calif., July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining. "We are pleased to announce Ms. Renae Cormier will lead our accounting, finance, investor relations and business strategy efforts as chief financial officer," said Doug Murphy-Chuto

      7/11/23 8:03:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors

      Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (NASDAQ:SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding shares, will immediately join Semler Scientific's board of directors as new independent directors. Mr. Semler will join the board as a Class II director standing for reelection at the 2023 annual meeting of stockholders and will be appointed as Chairman of the board, and Mr. Chang will join the board as a Class I director standing for reelection at the 2025 annual meeting of stockholders. The board will

      4/19/23 4:01:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Semler Scientific downgraded by B. Riley Securities with a new price target

      B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously

      11/2/22 6:23:13 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • B. Riley Securities reiterated coverage on Semler Scientific with a new price target

      B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $70.00 from $145.00 previously

      3/7/22 10:22:03 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • B. Riley Securities reiterated coverage on Semler Scientific with a new price target

      B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $145.00 from $175.00 previously

      11/2/21 10:00:22 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Financials

    Live finance-specific insights

    See more
    • Semler Scientific® Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC

      CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a

      5/13/25 4:01:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 165 BTC; Now Holds 3,467 BTC; YTD BTC Yield of 23.8%; Earnings Release Date and Conference Call for First Quarter 2025 Financial Results

      SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe

      4/30/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific® Announces Updated BTC & ATM Activity; Purchased Additional 111 BTC; Now Holds 3,303 BTC; YTD BTC Yield of 23.5%

      SANTA CLARA, Calif., April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24, 2025, Semler Scientific acquired 111 bitcoins for $10.0 million with an average purchase price of $90,124 per bitcoin, inclusive of fees and expenses, using p

      4/25/25 8:00:00 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    SEC Filings

    See more
    • Semler Scientific Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/4/25 5:00:25 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      6/4/25 8:00:10 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Semler Scientific Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events

      8-K - Semler Scientific, Inc. (0001554859) (Filer)

      5/23/25 8:00:12 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Semler Eric was granted 1,318 shares and bought $1,896,500 worth of shares (50,000 units at $37.93), increasing direct ownership by 9% to 621,721 units (SEC Form 4)

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      11/12/24 6:05:40 AM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

      SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

      12/12/24 4:16:00 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by Semler Scientific Inc.

      SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

      11/26/24 12:09:40 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

      SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

      11/12/24 4:15:46 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SMLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Brunell Natalie

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/22/25 6:19:47 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Brunell Natalie

      3 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/22/25 6:18:05 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Cormier Renae

      4 - Semler Scientific, Inc. (0001554859) (Issuer)

      5/5/25 9:12:05 PM ET
      $SMLR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care